Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Obesity doesn't just add pounds — it rewires the immune system. A new study found that bariatric surgery and significant weight loss can largely reverse those immune changes within 12 months, including a reduction in proinflammatory monocytes linked to conditions like rheumatoid arthritis. Whether weight-loss medications like GLP-1 agonists produce the same immune reset, however, remains unknown.
Obesity doesn't just add pounds — it fundamentally rewires the immune system. Research presented ahead of the 2026 German Rheumatology Congress shows that people with obesity have elevated levels of intermediate monocytes, the same proinflammatory immune cells found in excess in patients with rheumatoid arthritis (RA). This overlap suggests a shared inflammatory mechanism between metabolic and autoimmune disease.
The good news? These immune changes appear reversible. A study published in the International Journal of Obesity followed 111 adults with obesity through bariatric surgery and found that, after an average weight loss of 44.5 kg over 12 months, monocyte levels largely normalized — along with inflammatory markers, HbA1c, and blood lipids. One caveat: patients with type 2 diabetes showed persistently elevated monocyte counts throughout the study period.
By the Numbers:
Why it matters: If chronic inflammation from obesity is a treatable target — not just a side effect — rheumatology's anti-inflammatory toolkit (think IL-1 inhibitors or colchicine) could one day play a role in managing metabolic disease. Researchers are now testing this in a 200-patient randomized trial. The effects of GLP-1 drugs on immune normalization, however, remain an open and urgent question.
